News
GZPHF
2.140
NaN%
--
Guangzhou Baiyunshan Affirms Compliance on Related Party Disclosures in 2025 Report
TipRanks · 09/10 09:49
Baiyunshan Shareholders Approve All Resolutions at 2026 Extraordinary Meeting
TipRanks · 08/28 11:51
Baiyunshan’s GP Corp Aggregates Receivables Sales Into Disclosable HKEX Deal
TipRanks · 08/28 09:19
CICC Keeps Their Buy Rating on Guangzhou Baiyunshan Pharmaceutical Holdings Company (GZPHF)
TipRanks · 08/27 02:05
Baiyunshan Pharma Sets Mid-2026 Dividend in Unaudited Interim Report
TipRanks · 08/21 14:09
Guangzhou Baiyunshan Declares 2026 Interim Dividend and Sets H Share Record Date
TipRanks · 08/21 14:09
Guangzhou Baiyunshan Pharma Announces 2026 Interim Dividend and Tax Treatment Details
TipRanks · 08/21 14:08
Guangzhou Baiyunshan Pharma Calls August 2026 EGM to Vote on Board Pay
TipRanks · 08/07 11:12
Baiyunshan Unit Weighs Capital Raise to Bring In Strategic Investors
TipRanks · 07/10 10:37
Baiyunshan Pharma Sets Out Board Line-up and Committee Roles
TipRanks · 05/29 13:11
Guangzhou Baiyunshan Sets Final 2025 Dividend and Tax Terms for H-Share Investors
TipRanks · 05/29 13:08
Guangzhou Baiyunshan Shareholders Approve All AGM Resolutions and Board Changes
TipRanks · 05/29 12:59
Guangzhou Baiyunshan Unit Sells RMB1 Billion in Receivables in Ongoing Securitisation Drive
TipRanks · 05/22 09:38
Guangzhou Baiyunshan Appoints Liu Hong as Employee Representative Director to New Board
TipRanks · 05/15 10:10
Guangzhou Baiyunshan Pharma Sets Vote on New Three-Year Board Line-Up
TipRanks · 05/07 14:19
Guangzhou Baiyunshan Sets 2025 AGM to Vote on Profit Distribution and Director Pay
TipRanks · 05/07 13:20
Baiyunshan Q1 Revenue Rises as Profit Margins Narrow and Cash Outflows Ease
TipRanks · 04/27 11:10
Guangzhou Baiyunshan Pharma Sets Board Meeting to Review Q1 2026 Results
TipRanks · 04/14 08:40
Guangzhou Baiyunshan Proposes 2025 Cash Dividend After Solid Earnings
TipRanks · 03/20 14:42
Guangzhou Baiyunshan Proposes Final 2025 Cash Dividend of RMB 0.45 Per Share
TipRanks · 03/20 14:41
More
Webull provides a variety of real-time GZPHF stock news. You can receive the latest news about Guangzhou Pharmaceutical Co Lt through multiple platforms. This information may help you make smarter investment decisions.
About GZPHF
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is a China-based company primarily engaged in the business of pharmaceutical and health. The Company operates through five segments. Modern Chinese Medicine segment engages in the research and development, manufacturing and sales of proprietary Chinese medicines and natural medicines. Chemical Pharmaceutical Technology segment engages in the research and development, manufacturing, and sales of chemical drugs, chemical active pharmaceutical ingredients, and chemical intermediates. Natural Beverages segment engages in research and development, production, and sales of health-oriented products. Pharmaceutical Commerce segment engages in the wholesale, retail, and import/export of Western medicines, Chinese medicines, and medical devices. The Other segment primarily includes biotechnology innovation, consumer health, and medical services businesses. The Company mainly operates its businesses in the domestic and overseas markets.